MedTrace Logo

Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections

NCT01198262 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2010-09-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether the Cepheid GeneXpert system accurately detects Methicillin-Resistant and -Susceptible Staphylococcus aureus in blood cultures and wound swabs.

Conditions

  • Staphylococcus Aureus
  • Staphylococcal Skin Infections
  • Bacteremia

Sponsors & Collaborators

  • Baylor College of Medicine

    collaborator OTHER

  • Cepheid

    collaborator INDUSTRY

  • Michael E. DeBakey VA Medical Center

    lead FED

Principal Investigators

  • Daniel M Musher, MD · Michael E. DeBakey VA Medical Center

  • Mark Parta, MD · Michael E. DeBakey VA Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-08-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01198262 on ClinicalTrials.gov